Vaccine Equity through Social Enterprise could provide a new model for access?

‘Imperial College aims to develop a vaccine that is cheaper and easier to manufacture and is forming a partnership to sell it in low-income countries and Britain.’ Got everything crossed for the success of this endeavour.

A prominent British laboratory is forming a special partnership that would sidestep the drug industry to sell a potential vaccine against the coronavirus without profits or licensing fees in Britain and in low- and middle-income countries

Imperial College's potential vaccine could alter the landscape, in part because if successful it would be cheaper and easier to manufacture than others, the lead scientist on the project says nyti.ms/2BD0hW3 by @ddknyt

Imperial College's potential vaccine could alter the landscape, in part because if successful it would be cheaper and easier to manufacture than others, the lead scientist on the project says nyti.ms/2Ul0vru by @ddknyt

If successful, the lead scientist argued, its low-cost vaccine would appeal to the giant donors who typically supply low income countries. It could drive down prices elsewhere, too. nyti.ms/3dGLGHs by @ddknyt

UK Lab to Sidestep Drug Industry to Sell Potential #CoronaVirus #Vaccine “@imperialcollege aims to develop a vaccine that is cheaper and easier to manufacture and is forming a partnership to sell it in low-income countries and Britain.”

UK's Imperial College to develop a vaccine that is cheaper to sell in low-income countries & Britain in partnership with Morningside Ventures, founded by the Chan family, which is also a major donor to the T.H. Chan School of Public Health at Harvard.

“Imperial College’s self-amplifying RNA vaccine..would require a much smaller dose than the Moderna vaccine — 50 to 100 times smaller — which would greatly lower the cost per dose”

Let's see some more of this.

Will the FDA let Americans get access to the lower cost option? Rule 5 in my book #AnAmericanSickness about our dysfunctional health market. "There is no free choice. Patients are stuck. And they’re stuck buying American."

More from the UK: "To make the vaccine as widely and cheaply available as possible Imperial College is creating what it calls a “social enterprise”, VacEquity Global Health, in partnership with the investment firm Morningside Ventures, based in Hong Kong."